JP2024528935A5 - - Google Patents
Info
- Publication number
- JP2024528935A5 JP2024528935A5 JP2024506163A JP2024506163A JP2024528935A5 JP 2024528935 A5 JP2024528935 A5 JP 2024528935A5 JP 2024506163 A JP2024506163 A JP 2024506163A JP 2024506163 A JP2024506163 A JP 2024506163A JP 2024528935 A5 JP2024528935 A5 JP 2024528935A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- antigen
- binding fragment
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163228195P | 2021-08-02 | 2021-08-02 | |
| US63/228,195 | 2021-08-02 | ||
| PCT/US2022/074409 WO2023015170A2 (en) | 2021-08-02 | 2022-08-02 | Anti-cd38 antibodies, anti-cd3 antibodies, and bispecific antibodies, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528935A JP2024528935A (ja) | 2024-08-01 |
| JP2024528935A5 true JP2024528935A5 (enExample) | 2025-09-11 |
Family
ID=83049800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506163A Withdrawn JP2024528935A (ja) | 2021-08-02 | 2022-08-02 | 抗ｃｄ３８抗体、抗ｃｄ３抗体、及び二重特異性抗体、並びにその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250277051A1 (enExample) |
| EP (1) | EP4380977A2 (enExample) |
| JP (1) | JP2024528935A (enExample) |
| KR (1) | KR20240042009A (enExample) |
| CN (1) | CN117751144A (enExample) |
| AU (1) | AU2022323166A1 (enExample) |
| CA (1) | CA3226428A1 (enExample) |
| IL (1) | IL310024A (enExample) |
| WO (1) | WO2023015170A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117327186B (zh) * | 2023-07-12 | 2024-03-12 | 北京达成生物科技有限公司 | 结合mmp3蛋白的双特异性抗体及其用途 |
| WO2025162453A1 (zh) * | 2024-02-02 | 2025-08-07 | 北京昌平实验室 | 双特异性抗体前药及其应用 |
| WO2025201242A1 (en) * | 2024-03-25 | 2025-10-02 | Tavotek Biotherapeutics (Hong Kong) Limited | Antibodies targeting fap and lrrc15 and fusion proteins targeting hyaluronan and uses thereof |
| WO2025201240A1 (en) * | 2024-03-25 | 2025-10-02 | Tavotek Biotherapeutics (Hong Kong) Limited | Antibodies targeting cd3, cd28, and pd-l1 and uses thereof |
| CN119236080A (zh) * | 2024-09-29 | 2025-01-03 | 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） | 一种医药组合物在制备用于治疗多发性硬化药物中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ES2156149T3 (es) | 1992-12-04 | 2001-06-16 | Medical Res Council | Proteinas de union multivalente y multiespecificas, su fabricacion y su uso. |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| WO2006028936A2 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
| AU2006232287B2 (en) | 2005-03-31 | 2011-10-06 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| JP2009541275A (ja) | 2006-06-22 | 2009-11-26 | ノボ・ノルデイスク・エー／エス | 二重特異性抗体の生産 |
| WO2010129304A2 (en) | 2009-04-27 | 2010-11-11 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| UA118255C2 (uk) * | 2012-12-07 | 2018-12-26 | Санофі | Композиція, яка містить антитіло до cd38 і леналідомід |
| EP3699195A3 (en) * | 2014-03-28 | 2020-11-04 | Xencor, Inc. | Bispecific antibodies that bind to cd38 and cd3 |
| US11773166B2 (en) * | 2014-11-04 | 2023-10-03 | Ichnos Sciences SA | CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production |
| AU2016352676A1 (en) * | 2015-11-10 | 2018-05-31 | University Medical Center Hamburg - Eppendorf | ANTIGEN-binding polypeptides directed against CD38 |
| BR112020007002A2 (pt) * | 2017-10-10 | 2020-11-17 | Sanofi | anticorpos anti-cd38 e métodos de uso |
| KR20210086651A (ko) * | 2018-10-26 | 2021-07-08 | 테네오바이오, 인코포레이티드 | Cd38에 결합하는 중쇄 항체 |
| JP2022538461A (ja) * | 2019-07-01 | 2022-09-02 | ソレント・セラピューティクス・インコーポレイテッド | Ｃｄ３８およびｃｄ３に結合するヘテロ二量体抗体 |
-
2022
- 2022-08-01 US US18/294,406 patent/US20250277051A1/en active Pending
- 2022-08-02 IL IL310024A patent/IL310024A/en unknown
- 2022-08-02 CA CA3226428A patent/CA3226428A1/en active Pending
- 2022-08-02 JP JP2024506163A patent/JP2024528935A/ja not_active Withdrawn
- 2022-08-02 WO PCT/US2022/074409 patent/WO2023015170A2/en not_active Ceased
- 2022-08-02 KR KR1020247007197A patent/KR20240042009A/ko active Pending
- 2022-08-02 EP EP22758399.4A patent/EP4380977A2/en active Pending
- 2022-08-02 AU AU2022323166A patent/AU2022323166A1/en active Pending
- 2022-08-02 CN CN202280053639.9A patent/CN117751144A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024528935A5 (enExample) | ||
| CN106967172B (zh) | 抗ctla4-抗pd-1 双功能抗体、其药物组合物及其用途 | |
| JP2019107018A5 (enExample) | ||
| JP2021514664A5 (enExample) | ||
| CN112912396A (zh) | 抗cldn18.2抗体及其用途 | |
| IL310938A (en) | Anti-CCR8 antibodies and their uses | |
| TW202235441A (zh) | 抗cldn6抗體及其用途 | |
| JP2023539501A5 (enExample) | ||
| JP2024531409A5 (enExample) | ||
| AU2021353368B2 (en) | Anti-cd3 antibody and uses thereof | |
| JP2024544520A5 (enExample) | ||
| JP2021528047A5 (enExample) | ||
| JP2025038088A5 (enExample) | ||
| JP2024540148A5 (enExample) | ||
| JP2023511554A (ja) | インテグリンαｖβ８に結合する抗体およびその使用 | |
| JP2024546939A5 (enExample) | ||
| CN117659194B (zh) | 靶向egfr的纳米抗体、药物偶联物及其用途 | |
| CN103417965B (zh) | 一种含有抗vegf抗体的药物组合物 | |
| CA3206472A1 (en) | Anti-trpv6 monoclonal antibody and application thereof | |
| CN116496398B (zh) | 一种特异性结合CD44的v5外显子的抗体及其用途 | |
| WO2024131846A1 (en) | Antibody, antigen-binding fragment thereof, and pharmaceutical use thereof | |
| WO2024131835A1 (en) | Ligand-cytotoxicity drug conjugates and pharmaceutical uses thereof | |
| WO2023025187A1 (zh) | 特异性结合cd47的抗体、其重组溶瘤病毒及其用途 | |
| NZ785553A (en) | Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses | |
| CN121311503A (zh) | 靶向itga2的抗体、其抗体药物缀合物以及用途 |